Cargando…

Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis

BACKGROUND: Pneumococcal diseases are a leading cause of morbidity and mortality among children globally, and the burden of these diseases might be worsened by antimicrobial resistance. To understand the effect of pneumococcal conjugate vaccine (PCV) deployment on antimicrobial resistance in pneumoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrejko, Kristin, Ratnasiri, Buddhika, Hausdorff, William P, Laxminarayan, Ramanan, Lewnard, Joseph A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410609/ https://www.ncbi.nlm.nih.gov/pubmed/34485957 http://dx.doi.org/10.1016/S2666-5247(21)00064-1

Ejemplares similares

Pediatric outpatient visits and antibiotic use attributable to higher valency pneumococcal conjugate vaccine serotypes
por: King, Laura M, et al.
Publicado: (2023)

Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine
por: Elemraid, Mohamed A., et al.
Publicado: (2013)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India
por: Megiddo, Itamar, et al.
Publicado: (2018)

Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus
por: Lewnard, Joseph A., et al.
Publicado: (2022)

Pneumococcal Conjugate Vaccines and Otitis Media
por: Taylor, Sylvia, et al.
Publicado: (2012)

Antimicrobial susceptibility of Streptococcus pneumoniae in adult patients with pneumococcal pneumonia in an urban hospital in Mozambique
por: Bos, Jeannet C, et al.
Publicado: (2014)

Aetiology of paediatric pneumonia with effusion in the Dominican Republic and the potential impact of pneumococcal conjugate vaccines
por: Feris-Iglesias, Jesús, et al.
Publicado: (2014)

1384. Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance
por: Farkouh, Raymond, et al.
Publicado: (2020)

Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine
por: Kim, Gyu Ri, et al.
Publicado: (2023)

Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine
por: Esposito, Susanna, et al.
Publicado: (2016)

Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines
por: Wyllie, Anne L., et al.
Publicado: (2016)

Population Genetic Structure of Streptococcus pneumoniae in Kilifi, Kenya, Prior to the Introduction of Pneumococcal Conjugate Vaccine
por: Brueggemann, Angela B., et al.
Publicado: (2013)

Piliation of Invasive Streptococcus pneumoniae Isolates in the Era before Pneumococcal Conjugate Vaccine Introduction in Malawi
por: Kulohoma, Benard W., et al.
Publicado: (2013)

Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar
por: Raboba, Julia L, et al.
Publicado: (2021)

Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract
por: Lewnard, Joseph A, et al.
Publicado: (2021)

The overlooked pandemic of antimicrobial resistance
por: Laxminarayan, Ramanan
Publicado: (2022)

Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2018)

Nasopharyngeal colonization of Gambian infants by Staphylococcus aureus and Streptococcus pneumoniae before the introduction of pneumococcal conjugate vaccines
por: Usuf, E., et al.
Publicado: (2015)

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
por: Swarthout, Todd D., et al.
Publicado: (2020)

Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco
por: Diawara, Idrissa, et al.
Publicado: (2017)

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
por: Silva-Costa, Catarina, et al.
Publicado: (2018)

Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city
por: Lewnard, Joseph A., et al.
Publicado: (2023)

Population Snapshot of Streptococcus pneumoniae Causing Invasive Disease in South Africa Prior to Introduction of Pneumococcal Conjugate Vaccines
por: Ndlangisa, Kedibone M., et al.
Publicado: (2014)

Serotype Distribution of Clinical Streptococcus pneumoniae Isolates before the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Cambodia
por: Inghammar, Malin, et al.
Publicado: (2018)

Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia
por: Rockett, Rebecca J., et al.
Publicado: (2018)

Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation
por: Wolf, Asia-Sophia, et al.
Publicado: (2022)

AdcAII of Streptococcus pneumoniae Affects Pneumococcal Invasiveness
por: Brown, Lindsey R., et al.
Publicado: (2016)

2596. Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
por: Ramos, Bernice N, et al.
Publicado: (2023)

Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review
por: Taylor, Sylvia, et al.
Publicado: (2012)

Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco
por: Nzoyikorera, Néhémie, et al.
Publicado: (2023)

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
por: Hausdorff, William P, et al.
Publicado: (2010)

Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine
por: Fu, Han, et al.
Publicado: (2021)

Longitudinal characterization of nasopharyngeal colonization with Streptococcus pneumoniae in a South African birth cohort post 13-valent pneumococcal conjugate vaccine implementation
por: Dube, Felix S., et al.
Publicado: (2018)

Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use
por: Mosser, Jonathan F., et al.
Publicado: (2014)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
por: Sütçü, Murat, et al.
Publicado: (2017)

Effect of pneumococcal conjugate vaccine availability on Streptococcus pneumoniae infections and genetic recombination in Zhejiang, China from 2009 to 2019
por: Wu, Xueqing, et al.
Publicado: (2022)

Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru
por: Gonzales, Brayan E., et al.
Publicado: (2022)

Increase in prevalence of Streptococcus pneumoniae serogroup 24 in children upon introducing 13-valent pneumococcal conjugate vaccine in Japan
por: Ohkusu, Misako, et al.
Publicado: (2023)

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
por: Nakano, Satoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ni2262lo30ocipfhshjsfg04l2